CFAP206

Across TCGA pan-cancer cohorts, CFAP206 Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated CFAP206 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CFAP206 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CFAP206 expression acts as an unfavorable survival marker, although some lineages such as UCEC and STAD show a favorable association.

UCEC, HNSC, and LUSC are the cancer types where CFAP206 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.827	.006	30	view →
HNSC	DFS	Median	IV	0.171	0.548	.008	24	view →
LUSC	OS	Median	II,III,IV	0.240	0.633	.014	16	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
LUAD	OS	Median	III,IV	0.083	0.680	<.001	12	view →
STAD	DFS	Median	II,III,IV	1.000	0.368	.030	10	view →
KIRC	OS	Median	All	0.181	0.655	.046	6	view →
SARC	DFS	Median	All	1.000	0.305	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

CFAP206–UCEC (DFS)

Open the UCEC breakdown →